Charles C. Obihara
Research Subjects
Research Interests
Charles C. Obihara has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Anton G. M. Buiting
Laboratory of Medical Microbiology and Immunology, St Elisabeth Hospital, Tilburg, The Netherlands
1 shared publication Casper W. Bollen
Wilhelmina Children's Hospital, University Medical Center, Utrecht, The Netherlands
1 shared publication- Elisabeth G. W. Huijskens
Laboratory of Medical Microbiology and Immunology, St Elisabeth Hospital, Tilburg, The Netherlands
1 shared publication Jan L. L. Kimpen
Wilhelmina Children's Hospital, University Medical Center, Utrecht, The Netherlands
1 shared publication- John Wilhelmus Rossen
Department of Medical Microbiology and Infection Prevention, University Medical Center Groningen, University of Groningen, Groningen, Netherlands
1 shared publication Nulda Beyers
Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Health Sciences, Stellenbosch University, Stellenbosch, South Africa
1 shared publication
Latest Publications
- Open Access
- 19 November 2012
- Published by Springer Nature in Virology Journal
- Vol. 9 (1) , 276
Diagnostic value of respiratory virus detection in symptomatic children using real-time PCR
Acute respiratory tract infections are an important public health problem. Sensitive and rapid diagnostic techniques have been developed and are used in daily clinical practice. Here we evaluate the clinical relevance of detecting 20 common respiratory pathogens by molecular methods in a general pediatric clinic.
- 19 November 2012
- Published by Springer Nature in Virology Journal
- Vol. 9 (1) , 276
Open AccessDiagnostic value of respiratory virus detection in symptomatic children using real-time PCR
Acute respiratory tract infections are an important public health problem. Sensitive and rapid diagnostic techniques have been developed and are used in daily clinical practice. Here we evaluate the clinical relevance of detecting 20 common respiratory pathogens by molecular methods in a general pediatric clinic.
- 1 March 2008
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 38 (3) , 388-392
Hygiene hypothesis, allergy and BCG: a dirty mix?
- 1 March 2008
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 38 (3) , 388-392
Hygiene hypothesis, allergy and BCG: a dirty mix?
- 12 November 2007
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 18 (7) , 551-559
Mycobacterial infection and atopy in childhood: A systematic review
The epidemiological relation between mycobacterial infection and the prevalence of atopic disease in humans is still unclear. This is in contrast to studies in murine models in which a clear suppression of atopic symptoms was observed after exposure to mycobacteria or mycobacterial products. We therefore wanted to provide a systematic overview of the published literature on the relationship between mycobacterial infection and atopic disease and to evaluate the causal relationship in a meta‐analysis. The EMBASE and MEDLINE databases were searched systematically for papers published in the English literature (1966–2005) on the relation between mycobacterial infection and atopic disease. Original observational or interventional studies involving the paediatric population were included. Two authors independently reviewed articles for data on mycobacterial exposure and atopic disease outcome. Any differences were resolved by discussion. Of a total of 1201 hits, 23 studies (19 cross‐sectionals, three case–controls and one prospective cohort) met the inclusion criteria. Only a minority of studies (40%) observed an association between mycobacterial infection and the prevalence of atopic disease outcome. In the meta‐analysis, only studies containing data on mycobacterial exposure and atopic disease outcome variables were included. Only cross‐sectional studies, in which the relation between a positive tuberculin skin test and allergic symptoms was studied, observed statistically significant negative correlation (odds ratio 0.63; 95% confidence interval: 0.51–0.79). The results of this review show that the evidence of the relationship of mycobacterial infection and atopic disease is based on observations of cross‐sectional studies. In a meta‐analysis, calculations showed a high level of heterogeneity (I2) within studies with similar design making it difficult to pool effects. This may partly be explained by differences in the type and definition of mycobacterial infection and lack of uniformity in the definition of atopy. The results show that only a minority of studies in the literature shows any evidence of inverse relationship between mycobacterial exposure and atopic disease outcome. The fact that the present epidemiological evidence on the relationship between mycobacterial infection and the development of atopic disease is based mainly on cross‐sectional observational studies indicates the need for population‐based prospective studies to address this issue. This issue needs to be addressed in view of recent suggestions to developing mycobacterial‐based vaccines against atopic disease in the future.
- 12 November 2007
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 18 (7) , 551-559
Mycobacterial infection and atopy in childhood: A systematic review
The epidemiological relation between mycobacterial infection and the prevalence of atopic disease in humans is still unclear. This is in contrast to studies in murine models in which a clear suppression of atopic symptoms was observed after exposure to mycobacteria or mycobacterial products. We therefore wanted to provide a systematic overview of the published literature on the relationship between mycobacterial infection and atopic disease and to evaluate the causal relationship in a meta‐analysis. The EMBASE and MEDLINE databases were searched systematically for papers published in the English literature (1966–2005) on the relation between mycobacterial infection and atopic disease. Original observational or interventional studies involving the paediatric population were included. Two authors independently reviewed articles for data on mycobacterial exposure and atopic disease outcome. Any differences were resolved by discussion. Of a total of 1201 hits, 23 studies (19 cross‐sectionals, three case–controls and one prospective cohort) met the inclusion criteria. Only a minority of studies (40%) observed an association between mycobacterial infection and the prevalence of atopic disease outcome. In the meta‐analysis, only studies containing data on mycobacterial exposure and atopic disease outcome variables were included. Only cross‐sectional studies, in which the relation between a positive tuberculin skin test and allergic symptoms was studied, observed statistically significant negative correlation (odds ratio 0.63; 95% confidence interval: 0.51–0.79). The results of this review show that the evidence of the relationship of mycobacterial infection and atopic disease is based on observations of cross‐sectional studies. In a meta‐analysis, calculations showed a high level of heterogeneity (I2) within studies with similar design making it difficult to pool effects. This may partly be explained by differences in the type and definition of mycobacterial infection and lack of uniformity in the definition of atopy. The results show that only a minority of studies in the literature shows any evidence of inverse relationship between mycobacterial exposure and atopic disease outcome. The fact that the present epidemiological evidence on the relationship between mycobacterial infection and the development of atopic disease is based mainly on cross‐sectional observational studies indicates the need for population‐based prospective studies to address this issue. This issue needs to be addressed in view of recent suggestions to developing mycobacterial‐based vaccines against atopic disease in the future.